<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Volume Spike Investor &#187; biotech leaders</title>
	<atom:link href="http://vsinvestor.com/tag/biotech-leaders/feed" rel="self" type="application/rss+xml" />
	<link>http://vsinvestor.com</link>
	<description>Investing in stocks based on short term spikes in volume</description>
	<lastBuildDate>Sat, 05 Nov 2011 14:20:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2</generator>
		<item>
		<title>Exponential Volume Alert: Vanda Pharma (VNDA)</title>
		<link>http://vsinvestor.com/2008/07/exponential-volume-alert-vanda-pharma-vnda.html</link>
		<comments>http://vsinvestor.com/2008/07/exponential-volume-alert-vanda-pharma-vnda.html#comments</comments>
		<pubDate>Mon, 28 Jul 2008 13:40:05 +0000</pubDate>
		<dc:creator>247admin</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[biotech leaders]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[VNDA]]></category>

		<guid isPermaLink="false">http://www.vsinvestor.com/?p=213</guid>
		<description><![CDATA[Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) is one of the leading volume stocks this morning on NASDAQ. Unfortunately for holders, it is a major downside volume alert to yet another 52-week low.  An FDA non-approvable letter is the culprit. The biotech is down now more than 60% at $1.24 and its prior 52-week trading range was [...]]]></description>
			<content:encoded><![CDATA[<p>Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) is one of the leading volume stocks this morning on NASDAQ.  Unfortunately for holders, it is a major downside volume alert to yet another 52-week low.  An <a href="http://www.biohealthinvestor.com/2008/07/biotech-implosion-vanda-pharmaceuticals-vnda.html">FDA non-approvable letter</a> is the culprit.</p>
<p>The biotech is down now more than 60% at $1.24 and its prior 52-week trading range was $2.70 to $19.62.  As of 9:44 AM EST we have already seen more than 10 million shares trade hands.  As this now has a mere $33 million market cap, it looks like we&#8217;ll see more than its entire float trade hands today.  This one isn&#8217;t a true biotech zombie yet, but you&#8217;d never know it if you were just looking at its stock chart.</p>
<p>This is now under its cash levels on the books, but it will burn through much cash to fulfill its FDA obligatiosn to proceed.</p>
<p>Jon Ogg<br />
July 28, 2008</p>
]]></content:encoded>
			<wfw:commentRss>http://vsinvestor.com/2008/07/exponential-volume-alert-vanda-pharma-vnda.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

